PL-1 & PL-3: Blue Team Residents

Below are wonderful articles and resources to read before and during your Blue Team rotation:

Erythrocyte disorders

Screening for iron deficiency. Pediatrics in review 2002;23:171
Managing anemia in a pediatric office practice – Part 2. Pediatrics in review 2002;23:111
Managing anemia in a pediatric office practice – Part 1-Pediatrics in review 2002:23:75
Behavioral and developmental effects of preventing iron-deficiency anemia in healthy full-term infants. Pediatrics 2006:118:224-232
The management of Sickle cell disease –NIH publication No.02-2117- June 2002

Leukocyte disorders

Neutrophil abnormalities. Pediatrics in review 2003;24:52

Platelet disorders

Differential diagnosis and management of thrombocytopenia in childhood. Pediatr. Clin. North Amer. 2004; 51:1109-1140
Thrombocytopenia in Infants and Children. Pediatrics In Review. 32; 4: 135-151.
Thrombocytopenia During Childhood. Pediatrics In Review. 26; 11: 401-409.
Guideline on the investigation, management and prevention of venous thrombosis in children
How I Treat ITP
Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Coagulation disorders

Coagulation disorders – Pediatrics in review 2003;24:83
Von Willebrand disease – Pediatrics in review 2005;26:302
Recessively inherited coagulation disorders – Blood 2004;104:1243-1252

Neoplastic disorders

Childhood Leukemia Pediatrics in Review.2010;31:234.
Late effects in childhood cancer – Pediatrics 2007;119:554-568.
Bone Lesions: Benign and Malignant. Pediatrics In Review. 31;9:355 -363.
Childhood Brain Tumors. Pediatrics in Review 2013; 34:63-78.

Useful Websites

Blue Team Intern Responsibilities

This PGY1 resident will have primary responsibility for the care of patients on the Blue team, which will consist of hematology/oncology patients receiving chemotherapy as well as patients with general hematology problems such as sickle cell anemia, ITP, hemophilia, neutropenia and sepsis. When possible the blue intern should also see patients in the Hematology/Oncology Clinic with attending supervision. Clinic visits will be for initial diagnosis and for follow-up on patients who have been or are being treated for problems such as leukemia, lymphoma, osteosarcoma, sickle cell disease, hemophilia, ITP and other medical issues.

The Blue intern will spend 3 day time weeks on service and 1 week of combined night float (covering both Gray and Blue service) per rotation. Morning sign-in for the Blue Team should occur as a team at 6:45am Monday through Friday, and evening sign-out should occur as a team at 5:30pm. Weekend morning sign-in should be coordinated with the team in order to allow preparation for rounds, and ideally, the presence of the SAR on rounds. On weekends the post-call intern will sign out prior to rounds at 7am. Please note that chemotherapy orders must be written and/or signed by an attending.

Blue Team Senior Responsibilities

This PGY3 resident will have primary responsibility for supervising the care of patients on the Blue team, which will consist of hematology/oncology patients receiving chemotherapy as well as patients with general hematology problems such as sickle cell anemia, ITP, hemophilia, neutropenia and sepsis. The senior resident is expected to supervise the Blue intern prior to morning rounds as well as be present on morning rounds. In the afternoon, the resident will be covering another floor team while that team’s senior is in continuity clinic. Sign out is in the Resident Library for sign-out at 5:30pm.

The Blue Senior resident will take SAR call on the weekends and will have one weekend per month off.